← Back to Search

1 for Fatigue

Phase 3
Waitlist Available
Led By Amy Matecki, MD
Research Sponsored by Alta Bates Summit Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months
Awards & highlights

Study Summary

This is a randomized, placebo controlled study in cancer patients reporting fatigue persisting for at least two months following completion of chemotherapy. Subjects will receive 6 weeks of either acupuncture or placebo treatment as a means of evaluating whether acupuncture reduces chronic fatigue after chemotherapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months
This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To determine whether acupuncture reduces chronic fatigue after chemotherapy more effectively than placebo
Secondary outcome measures
To examine predictors of response to acupuncture treatment in terms of baseline symptoms, hemoglobin, age, sex, time since chemotherapy, and concurrent treatment
To examine the effect of acupuncture on levels of physical activity and quality of life
To examine the long term effects of acupuncture treatment on fatigue

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: 1Active Control1 Intervention
Acupuncture
Group II: 2Placebo Group1 Intervention
Placebo Acupuncture

Find a Location

Who is running the clinical trial?

Alta Bates Summit Medical CenterLead Sponsor
4 Previous Clinical Trials
289 Total Patients Enrolled
1 Trials studying Fatigue
20 Patients Enrolled for Fatigue
Amy Matecki, MDPrincipal InvestigatorAlta Bates Summit Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025